NOVA University Lisbon (NOVA) has once again stood out in the national panorama of scientific research, within the framework of the evaluation of research and development (R&D) units carried out by the Foundation for Science and Technology (FCT).
According to the results of the evaluation of R&D units for 2023/2024, which have just been published, 93% of NOVA’s R&D units were rated “excellent” and “very good”. Furthermore, by showing an improvement over the previous year, they consolidate NOVA’s position as one of the top performing higher education institutions nationally.
“These exceptional results demonstrate the commitment of the entire NOVA scientific community to developing excellent research with an impact on society,” says Isabel Rocha, Vice-Rector for Research and Innovation at Universidade Nova de Lisboa.
Of the 41 NOVA R&D units (UIDs) evaluated, 29 were classified as “excellent”, 9 as “very good” and 3 as “good”. The number of NOVA UIDs classified as “Excellent” increased by 20% compared to the previous year and represents 71% of the total number of UIDs with which the University is associated, a percentage well above the 40% of the national average of UIDs that received this classification.
All of NOVA’s organic units now have at least one R&D unit classified as “Excellent”, reinforcing the University’s transversal commitment to scientific excellence in all fields of knowledge.
In recognition of the quality demonstrated, the Research Units with which NOVA is associated will benefit from a total of 126 million euros in funding allocated under the 2023/2024 Multi-Annual Programme for the Financing of R&D Units.
NOVA congratulates all NOVA R&D Unit Coordinators and their teams for their continued commitment to excellence. With this achievement, NOVA strengthens its strategic role in the national and international science and technology system, actively contributing to the production of knowledge, innovation and sustainable development.
At the national level, entities with a performance rating of “Excellent” or “Very Good” have approved funding of R$609.8 million for the period 2025-2029. Of this amount, R$110 million comes from the Recovery and Resilience Plan, with an execution deadline of 30 June 2026.
More details about the Assessment of Research and Development (R&D) Units can be found here.